9 completed, 2 not yet recruiting, 2 terminated, 1 active not recruiting. 6 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Completed 2, Not yet recruiting 2, Active not recruiting 1, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Neurogenic Bladder Disorder: new trials by email Literature Review of Neurogenic Bladder Disorder trials Research Report on Neurogenic Bladder Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Rapid UTI Diagnostics in Lower Urinary Tract Dysfunction Among Catheter Users urine Resazurin Reduction Ratio, USQNB - Neurogenic Bladder Disorder, Lower Urinary Tract Disorder | Not applicable | Not yet recruiting | Medstar Health Research Institute | 100 | 2026-09-01 | 2026-09-11 |
| Essential Oils for Urinary Symptoms in Multiple Sclerosis Patients Essential Oil Blend (Lavender, Rosemary), Neutral Carrier Oil (Apricot Kernel Oil) - Multiple Sclerosis (MS), Neurogenic Bladder Disorder | Not applicable | Not yet recruiting | University of Oran 1 | 60 | 2026-09-01 | 2026-05-20 |
| Turkish Version of the Neurogenic Bladder Symptom Score Short Form Neurogenic Bladder Disorder, Spinal Cord Injury | Completed | Gaziantep Islam Science and Technology University | 120 | 2026-03-27 | 2026-07-23 | |
| Define Final Selection Choice Criteria for a Coloplast Catheter Ensuring Highest Patient Satisfaction Via Surveys (EVA). Questionnaires : Patient questionnaire on catheter use and satisfaction, IC-Di-Q, and I-CAT - Neurogenic Bladder Disorder, Non-Neurogenic Bladder | Not applicable | Terminated | Coloplast NV/SA | 22 | 2025-10-21 | 2026-08-17 |
| Use of Wearables Following Cystectomy- Part II Fitbit Sense 2, Smartphone application survey - Bladder Cancer, Neurogenic Bladder Disorder | Not applicable | Active not recruiting | University of Pittsburgh | 50 | 2025-09-19 | 2026-09-08 |
| Urinary Artificial Sphincter in Children Urinary Artificial Sphincter - Neurogenic Bladder Disorder, Bladder Dysfunction | Completed | University Hospital, Clermont-Ferrand | 15 | 2022-11-20 | 2024-12-16 | |
| Urinary Calculi After Bladder Augmentation in Children Bladder Augmentation - Calculi, Urinary, Neurogenic Bladder Disorder | Completed | University Hospital, Clermont-Ferrand | 34 | 2022-11-20 | 2024-12-16 | |
| Effects of Pelvic Floor Strengthening and Relaxation Exercises in Women Diagnosed With Multiple Sclerosis Pelvic Floor Strengthening Exercises, Pelvic Floor Relaxation Exercises, Combined Pelvic Floor Exercises - Multiple Sclerosis, Neurogenic Bladder Disorder | Not applicable | Completed | Gazi University | 24 | 2022-02-02 | 2026-03-20 |
| Complications of Bladder Augmentation in Children Neurogenic Bladder Disorder, Spina Bifida | Completed | University Hospital, Clermont-Ferrand | 87 | 2020-11-01 | 2024-12-13 | |
| Bladder Neck Surgery in Children with Neurogenic Bladder Bladder Neck Surgery - Incontinence, Bladder Dysfunction | Completed | University Hospital, Clermont-Ferrand | 46 | 2020-01-01 | 2024-12-16 | |
| Predictive Urodynamic Parameters for The Treatment Efficacy of Onabotulinum A Toxin in Neurogenic Lower Urinary Tract Dysfunction Botox 200 UNT Injection - Neurogenic Bladder Disorder | Completed | University of Gaziantep | 74 | 2013-09-01 | 2024-07-03 | |
| Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions SAF312, Placebo to SAF312 - Neurogenic Urinary Bladder, Neurogenic Bladder Disorder | Phase 2 | Terminated | Novartis Pharmaceuticals | 9 | 2012-01-01 | 2020-12-19 |
| Medico-economical Impact of the Brindley Neurosurgical Technique in France Brindley technique (bladder system) - Spinal Cord Injuries, Neurogenic Bladder Disorder | Not applicable | Completed | University Hospital, Bordeaux | 53 | 2005-06-01 | 2012-06-14 |
| Efficacy and Tolerability of Propiverine Hydrochloride in Patients With Neurogenic Detrusor Overactivity Propiverine hydrochloride ER (extended release), Propiverine hydrochloride IR (immediate release) - Neurogenic Urinary Bladder Disorder, Urinary Bladder, Neurogenic | Phase 3 | Completed | APOGEPHA Arzneimittel GmbH | 66 | 2004-12-01 | 2012-02-10 |
Urinary Bladder, Neurogenic (14) · Spinal Dysraphism (4) · Multiple Sclerosis (3) · Spinal Cord Injuries (3) · Urinary Incontinence (3) · Urinary Tract Infections (2) · Disease (1) · Lower Urinary Tract Symptoms (1) · Paraplegia (1) · Quadriplegia (1) · Urinary Bladder Neoplasms (1) · Urinary Bladder, Overactive (1) · Urinary Calculi (1) · Urinary Retention (1) · Urologic Diseases (1)
Female Urogenital Diseases (14) · Female Urogenital Diseases and Pregnancy Complications (14) · Male Urogenital Diseases (14) · Nervous System Diseases (14) · Neurologic Manifestations (14) · Pathological Conditions, Signs and Symptoms (14) · Signs and Symptoms (14) · Urinary Bladder Diseases (14) · Urogenital Diseases (14) · Urologic Diseases (13) · Congenital Abnormalities (4) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Nervous System Malformations (4) · Neural Tube Defects (4) · Urination Disorders (4)
Urinary Sphincter, Artificial (1) · propiverine (1)
University Hospital, Clermont-Ferrand (4) · APOGEPHA Arzneimittel GmbH (1) · Coloplast NV/SA (1) · Gazi University (1) · Gaziantep Islam Science and Technology University (1) · Medstar Health Research Institute (1) · Novartis Pharmaceuticals (1) · University Hospital, Bordeaux (1) · University of Gaziantep (1) · University of Oran 1 (1) · University of Pittsburgh (1)
France (5) · Germany (2) · Turkey (Türkiye) (2) · United States (2) · Algeria (1) · Austria (1) · Belgium (1) · Netherlands (1) · Romania (1) · Switzerland (1)
Ana Valeria Aguirre Guemez, MD (1) · Bruce Jacobs, MD, MPH (1) · Christelle Destinval (1) · Jean-Rodolphe Vignes, Doctor (1) · Roger Houben, PhD MBA (1)